Skip to content
  • Home
  • M & A
  • Opinion
  • Rumors
  • M&A News
  • About Us
  • Register
    • Log In
  • Contact Us
  • Home
  • M & A
  • Opinion
  • Rumors
  • M&A News
  • About Us
  • Register
    • Log In
  • Contact Us
M&A Today

M&A Today

A website dedicated to the world of M&A – transactions, ideas, insights and other relevant M&A-related resources.

  • Home
  • M & A
  • Opinion
  • Rumors
  • M&A News
  • About Us
  • Register
    • Log In
  • Contact Us

Tag: Pharma

How Consolidated Can the Pharmaceuticals Industry Become?
Mergers & Acquisitions 

How Consolidated Can the Pharmaceuticals Industry Become?

May 9, 2016 by M&A Today

With Abbott’s () $25Bn bid for St. Jude Medical () made official on Thursday, and with this being only yet one more multi-billion-Dollar bid in the space this year, one is left wondering how much longer will this sector be able to…

Continue Reading
When leading the Generics market is not enough
Mergers & Acquisitions Opinion 

When leading the Generics market is not enough

November 3, 2015 by M&A Today

Teva Pharmaceuticals () is no less than the world’s #1 drug company in the Generics segment. For those who still wonder, Generics, in short, are drugs made by plants others than those having developed – and patented – the active ingredient. New…

Continue Reading
And the Pharma consolidation continues
Mergers & Acquisitions 

And the Pharma consolidation continues

October 6, 2015 by M&A Today

Today’s Pharma big deal is in the compounded drug segment. AmerisourceBergen, not at all shy when it comes to acquisitions, announced its acquisition of PharMEDium Healthcare Holdings from Private Equity Fund Clayton, Dubilier & Rice for a mere $2.575 Billion. More than a good exit for…

Continue Reading
Endo Closes on Par Pharma – Stock goes down 10%
Mergers & Acquisitions 

Endo Closes on Par Pharma – Stock goes down 10%

September 28, 2015 by M&A Today

As discussed here previously, the FTC approved Endo’s acquisition of Par Pharmaceuticals last Friday, making the $8Bn deal official. The acquisition is aligned with Endo’s strategy and makes a lot of sense in terms of amplifying the company’s product portfolio, presence in…

Continue Reading
Endo International gets green light to buy Par Pharmaceuticals with only a couple of tweaks
Mergers & Acquisitions 

Endo International gets green light to buy Par Pharmaceuticals with only a couple of tweaks

September 26, 2015 by M&A Today

I love the Pharma space, M&A-wise. It’s a huge market with many players and with a bunch of firms thriving in executing roll-up acquisition strategies. The other reason why I love the Pharma space is for the readily available information in the space….

Continue Reading

What we write about

Acquisition Alcohol Beer Consolidation Consumer Controversial Crisis cross-border crowdfunding Cryptocurrency Deal Fatigue debt Drug Emerging Markets Expansion global economy Globalization Insights Integration International Markets Investment IPO Latin America Leveraged Buy-Out Merger Monopoly PE Exit Pet Pharma Post Merger Public Markets Publishing Retail Sharing Economy Tech Tech Disruption Technology Telecom Thoughts Trend Turnaround Unicorns

Search on this site

Finance News

Latest on Twitter

@ ·
06.03.23

Reply on Twitter Retweet on Twitter Like on Twitter Twitter
Load More...
email
All rights reserved - M&A Today - © 2015-2023 - Privacy Policy